These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
628 related articles for article (PubMed ID: 24555586)
21. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. Fletcher JW; Kymes SM; Gould M; Alazraki N; Coleman RE; Lowe VJ; Marn C; Segall G; Thet LA; Lee K; J Nucl Med; 2008 Feb; 49(2):179-85. PubMed ID: 18199626 [TBL] [Abstract][Full Text] [Related]
22. [Comparative analysis of the informative value of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in the differential diagnosis of solitary lung masses]. Tlostanova MS; Avetisian AO; Kozak AR Vestn Rentgenol Radiol; 2014; (3):13-9. PubMed ID: 25782293 [TBL] [Abstract][Full Text] [Related]
23. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572 [TBL] [Abstract][Full Text] [Related]
24. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
25. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection. Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256 [TBL] [Abstract][Full Text] [Related]
27. Pediatric bone sarcoma: diagnostic performance of ¹⁸F-FDG PET/CT versus conventional imaging for initial staging and follow-up. Quartuccio N; Fox J; Kuk D; Wexler LH; Baldari S; Cistaro A; Schöder H AJR Am J Roentgenol; 2015 Jan; 204(1):153-60. PubMed ID: 25539251 [TBL] [Abstract][Full Text] [Related]
28. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. Vikram R; Yeung HD; Macapinlac HA; Iyer RB AJR Am J Roentgenol; 2008 Nov; 191(5):1545-51. PubMed ID: 18941099 [TBL] [Abstract][Full Text] [Related]
29. Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study. Iagaru A; Mittra E; Yaghoubi SS; Dick DW; Quon A; Goris ML; Gambhir SS J Nucl Med; 2009 Apr; 50(4):501-5. PubMed ID: 19289439 [TBL] [Abstract][Full Text] [Related]
30. Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results. Hahn S; Heusner T; Zhou X; Zhan Y; Peng Z; Hamami M; Forsting M; Bockisch A; Antoch G Rofo; 2010 Mar; 182(3):243-7. PubMed ID: 19859858 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5. Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611 [TBL] [Abstract][Full Text] [Related]
32. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906 [TBL] [Abstract][Full Text] [Related]
33. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
34. Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. Metser U; Miller E; Lerman H; Even-Sapir E AJR Am J Roentgenol; 2007 Nov; 189(5):1203-10. PubMed ID: 17954662 [TBL] [Abstract][Full Text] [Related]
35. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136 [TBL] [Abstract][Full Text] [Related]
36. [Development of a predicting model to estimate the probability of malignancy of solitary pulmonary nodules]. Tian R; Su MG; Tian Y; Li FL; Kuang AR Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 May; 43(3):404-8. PubMed ID: 22812247 [TBL] [Abstract][Full Text] [Related]
37. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Cronin P; Dwamena BA; Kelly AM; Carlos RC Radiology; 2008 Mar; 246(3):772-82. PubMed ID: 18235105 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies. O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694 [TBL] [Abstract][Full Text] [Related]
39. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]